JobsOhio is a private nonprofit corporation wholly funded by an independent private source –the profits from the JobsOhio Beverage System (JOBS) liquor enterprise –that JobsOhio purchased in 2013 and manages today.

JOBS liquor profits provide a stable funding source which allows JobsOhio to utilize a longer-term horizon for funding economic development activities. No public or taxpayer dollars are used

Ipsen is a global biopharmaceutical company with a focus on bringing transformative medicines to patients in three therapeutic areas: Oncology, Rare Disease and Neuroscience. Its pipeline is fueled by internal and external innovation and supported by nearly 100 years of development experience and global hubs in the U.S., France and the U.K. Ipsen has teams in more than 40 countries and their partnerships around the world allow medicines to be brought to patients in more than 100 countries.

Ipsen is listed in Paris (Euronext: IPN) and in the U.S. through a Sponsored Level I American Depositary Receipt program (ADR: IPSEY).

A major player in regional economic financing, supporting 1 in 5 SME and 1 in 3 mid-sized companies through its 110 Business Centers located across all regions of France and its overseas territories (over $15 billion in financing by 2024). Caisse d’Epargne, a local cooperative banking network, supports businesses in their growth and transition projects. More than 38,000 businesses (SMEs, startups, mid-sized companies, and large corporate clients) are supported by our local experts, regardless of their size or industry.

Discover their dedicated sales teams: 400 relationship managers working closely with regional ecosystems to support your projects with responsiveness and expertise. A local support system reinforced by experts in cash management, international business, or innovation, for example. Being of service to you also means supporting you on your transformation journey and fully understanding your transition challenges, whether environmental, social, or governance-related.

With concrete solutions to meet your needs and support your development projects:

Day-to-day management of your cash flows and online payment solutions;
Financing for capital expenditures and working capital;
Financing for land and real estate in the broadest sense (establishment, relocation, capacity expansion, headquarters, etc.);
Financing of investments in production assets (machinery, equipment, IT, etc.) and mobility solutions;
Strategic risk management for operations (energy, raw materials, etc.);
Support for transformative transactions (external growth, IPOs, etc.);
Implementation of insurance, employee savings, and retirement solutions for your employees;
Investment of your excess cash;
Wealth optimization;
Support for your import-export operations and international expansion projects.

ICOSA is a European intellectual property firm, founded in 2009, specializing in supporting stakeholders in the Health, Cosmetics, Food, Environment, and Tech industries.
ICOSA help companies and investors address intellectual property challenges by protecting, securing, and maximizing the value of their innovations worldwide (patents, trademarks, designs, contracts, etc.).

With a team of 90 multidisciplinary professionals, they combine technical expertise, business vision, and strategic insight to guide clients through every stage of their growth, from start-ups to multinational corporations.
Based in France and Belgium, ICOSA positions itself as a specialist in intellectual property strategy, a trusted partner at the heart of innovation ecosystems, and a key player in creating value across European and global markets.

Efor Group is a global leader in quality and regulatory compliance consulting for the Life Sciences industry. Founded in 2013, the company supports pharmaceutical, biotechnology, and medical device organizations in securing their manufacturing operations and accelerating the delivery of innovative therapies to patients.

With more than 3,000 experts across 18 countries, Efor provides end-to-end solutions covering Commissioning, Qualification and Validation (CQV), Quality Management, and Engineering Compliance. Its approach combines deep technical expertise with a strong understanding of regulatory requirements, enabling clients to ensure the reliability, safety, and compliance of their production systems throughout the entire product lifecycle.

Efor’s innovative model is based on flexible, modular, and tailor-made solutions designed to adapt to each client’s specific challenges, from early clinical phases to large-scale commercial manufacturing. By removing technical and regulatory barriers, the company helps reduce time-to-market while maintaining the highest standards of quality and patient safety.

Committed to sustainable growth, Efor integrates environmental and social responsibility into its operations and aims to become a global benchmark in Life Sciences consulting.

Natixis Corporate & Investment Banking (part of Groupe BPCE the second largest banking group in France) is a global financial institution offering advisory, financing, and capital markets services. Within Its Corporate & Investment Banking (CIB) division, the Healthcare Sector’team supports pharma, MedTech, and healthcare services with deep sector and scientific expertise. Active across Europe, Natixis aims to be the go-to bank for healthcare clients.

They focus on three specific areas: pharmaceuticals (big and midcap pharma, biotech), healthcare infrastructure and services (clinics, hospitals, nursing homes, laboratories, CDMO/CMO) and MedTech. Natixis has a global on-the-ground presence and are one of the most active banks within the industry in Europe aiming to become the healthcare “go-to-bank” for their core clients.

Shahin Gharakhanian MD, DPH, is a Physician-Executive with Expertise in Pharmaceutical Medicine, Leadership and Management, and an international track record. His passion is Patient-focused Programs for Novel Drug & Vaccine Development, Approval and Launch. He aims and strives to add value to Companies, notably by acting as Chief Medical Officer, via SABs (Scientific Advisory Boards) or ad hoc as Program Executive.

Dr Gharakhanian has conducted projects with 30 different global companies, 20 different brands and 4 NDA/MAA and/or new drug launches, including a blockbuster in 2011. These involved a variety of therapeutic areas and geographic regions [Asia, Canada, and EU, USA]. Leader-Builder with a track record of setting up three fully operational departments, one pharmaceutical company department, one CRO, one academic clinical unit and four LLCs.

Boston Paris Biotechnology Summit™ MISSION:

An exclusive, Trans-Atlantic bridge designed to foster innovative synergies between biotech and pharma companies, healthcare-focused cities and regional clusters and institutional, philanthropic and strategic investors. The Summit’s intent is to spark projects, their financing and strategic deals in order to solve unmet medical needs and thus improve patient lives globally.

ORCOM US is a US based accounting and tax services firm with American Certified Public Accountants (CPAs), ACCA and French diplomes “Experts-comptables” (French CPA licensees).

ORCOM US world-class global team brings together the art of accounting and international taxation with the science of technology to help its clients achieve their personal or business goals. They drive their mission through a culture of excellence: constantly improving and learning, supporting performance, and succeeding with integrity.